Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

High Prevalence Of Extramedullary Relapse In Patients With Multiple Myeloma Treated With Novel Biological Agents

Silvia Mangiacavalli, MD, Alessandra Pompa, MD, Cristiana Pascutto, PhD, Virginia Ferretti, DR, Lara Pochintesta, MD, Federica Cocito, MD, Marzia Varettoni, Mario Lazzarino, Prof, Mario Cazzola, MD, Alessandro Corso, MD

Blood (2013) 122 (21): 1896.

https://doi.org/10.1182/blood.V122.21.1896.1896

Published: 2013

Journal Articles

CpG Oligonucleotide Combined with Interleukin-2 Reveals Unexpected Chromosomal Lesions In B-CLL

Paolo Bernasconi, MD, Marina Boni, PhD, Irene Dambruoso, PhD, Ilaria Giardini, PhD, Paola Maria Cavigliano, PhD, Barbara Rocca, BSc, Rita Zappatore, PhD, Celeste Calvello, PhD, Marilena Caresana, PhD, Lara Pochintesta, MD, Silvia Zibellini, Mario Lazzarino, Prof, Ester Orlandi, MD

Blood (2010) 116 (21): 2411.

https://doi.org/10.1182/blood.V116.21.2411.2411

Published: 2010

Journal Articles

Dose Changing and Discontinuation of Imatinib In Patients Affected by Philadelphia Positive Chronic Myeloid Leukemia: a Longitudinal Analysis, a Single Centre Experience.

Serena Merante, MD, Cristiana Pascutto, PhD, Ester Orlandi, MD, Lara Pochintesta, MD, Marina Boni, BSc, Celeste Calvello, BSc, Barbara Rocca, BSc, Paolo Bernasconi, MD, Mario Lazzarino, Prof

Blood (2010) 116 (21): 4478.

https://doi.org/10.1182/blood.V116.21.4478.4478

Published: 2010

Journal Articles

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Alessandro Corso, MD, Silvia Mangiacavalli, MD, Federica Cocito, MD, Cristiana Pascutto, Cesare Astori, MD, Marzia Varettoni, MD, Ester Orlandi, MD, Patrizia Zappasodi, MD, Silvia Rizzi, MD, Ilaria Ambaglio, MD, Mario Lazzarino, Prof, Mario Cazzola, MD

Blood (2010) 116 (21): 3037.

https://doi.org/10.1182/blood.V116.21.3037.3037

Published: 2010

Journal Articles

Has Cytogenetic Evolution Any Prognostic Relevance in Myelodysplastic Syndromes (MDS)? A Study on 153 Patients.

Paolo Bernasconi Prof, Catherine Klersy, MD, Marina Boni, MD, Paola Maria Cavigliano, MD, Silvia Calatroni, MD, Ilaria Giardini, MD, Barbara Rocca, MD, Rita Zappatore, MD, Irene Dambruoso, MD, Marilena Caresana, MD, Mario Lazzarino Prof

Blood (2007) 110 (11): 2460.

https://doi.org/10.1182/blood.V110.11.2460.2460

Published: 2007

NARROW

High Prevalence Of Extramedullary Relapse In Patients With Multiple Myeloma Treated With Novel Biological Agents

CpG Oligonucleotide Combined with Interleukin-2 Reveals Unexpected Chromosomal Lesions In B-CLL

Dose Changing and Discontinuation of Imatinib In Patients Affected by Philadelphia Positive Chronic Myeloid Leukemia: a Longitudinal Analysis, a Single Centre Experience.

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Has Cytogenetic Evolution Any Prognostic Relevance in Myelodysplastic Syndromes (MDS)? A Study on 153 Patients.

Email alerts

ASH Publications

American Society of Hematology

High Prevalence Of Extramedullary Relapse In Patients With Multiple Myeloma Treated With Novel Biological Agents

CpG Oligonucleotide Combined with Interleukin-2 Reveals Unexpected Chromosomal Lesions In B-CLL

Dose Changing and Discontinuation of Imatinib In Patients Affected by Philadelphia Positive Chronic Myeloid Leukemia: a Longitudinal Analysis, a Single Centre Experience.

Fotemustine IN COMBINATION with BORTEZOMIB and DEXAMETHASONE: Encouraging PRELIMINARY RESULTS FROM A PHASE II STUDY On Relapsed REFRACTORY MYELOMA PATIENTS

Has Cytogenetic Evolution Any Prognostic Relevance in Myelodysplastic Syndromes (MDS)? A Study on 153 Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only